{"SPADE_UN_15645": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_15645", "Peptide Name": "HS7", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "GAISAPKLQIND", "Sequence Length": 12, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:CT26 (IC50=4.4±0.4 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "programmed cell death protein 1", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C53H91N15O18", "Mass": 1226.38, "PI": 6.09, "Net Charge": 0, "Hydrophobicity": -0.07, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Design, synthesis and evaluation of PD-L1 peptide antagonists as new anticancer agents for immunotherapy", "Pubmed ID": "33360579", "Reference": "Bioorg Med Chem. 2021 Jan 15;30115951.", "Author": "Orafaie A, Sadeghian H, Bahrami AR, Rafatpanah H, Matin MM.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=33360579"}], "Frequent Amino Acids": "AID", "Absent Amino Acids": "CEFHMORTUVWY", "Basic Residues": 1, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 6, "Positive Residues": 1, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08434", "Similarity": 1.0, "Sequence": "KKIGAIKKWGAIKKIGAI"}, {"SPADE_ID": "SPADE_N_08435", "Similarity": 1.0, "Sequence": "KIKGAIKWKGAIKIKGAI"}, {"SPADE_ID": "SPADE_UN_27518", "Similarity": 1.0, "Sequence": "KKIGAIKKWGAIKKIGAI"}]}}}